Cyclin D1, cancer progression, and opportunities in cancer treatment S Qie, JA Diehl Journal of molecular medicine 94, 1313-1326, 2016 | 693 | 2016 |
Functional significance of VEGF-a in human ovarian carcinoma: role in vasculogenic mimicry J Wang, T Sun, X Zhao, S Zhang, Q Gu, X Wang, N Zhao, S Qie, B Sun Cancer biology & therapy 7 (5), 758-766, 2008 | 139 | 2008 |
ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation S Qie, C Chu, W Li, C Wang, N Sang Journal of cellular biochemistry 115 (3), 498-509, 2014 | 125 | 2014 |
Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors B Sun, S Qie, S Zhang, T Sun, X Zhao, S Gao, C Ni, X Wang, Y Liu, ... Human pathology 39 (3), 444-451, 2008 | 122 | 2008 |
Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells VJ Gennaro, TJ Stanek, AR Peck, Y Sun, F Wang, S Qie, KE Knudsen, ... Proceedings of the National Academy of Sciences 115 (40), E9298-E9307, 2018 | 115 | 2018 |
Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma S Qie, A Yoshida, S Parnham, N Oleinik, GC Beeson, CC Beeson, ... Nature Communications 10 (1), 1296, 2019 | 95 | 2019 |
Carbon source metabolism and its regulation in cancer cells C Yin, S Qie, N Sang Critical Reviews™ in Eukaryotic Gene Expression 22 (1), 2012 | 85 | 2012 |
RNA-binding protein FXR1 regulates p21 and TERC RNA to bypass p53-mediated cellular senescence in OSCC M Majumder, R House, N Palanisamy, S Qie, TA Day, D Neskey, JA Diehl, ... PLoS genetics 12 (9), e1006306, 2016 | 77 | 2016 |
Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target S Qie, N Sang Journal of Experimental & Clinical Cancer Research 41 (1), 161, 2022 | 64 | 2022 |
Cyclin D degradation by E3 ligases in cancer progression and treatment S Qie, JA Diehl Seminars in cancer biology 67, 159-170, 2020 | 60 | 2020 |
Glutamine depletion and glucose depletion trigger growth inhibition via distinctive gene expression reprogramming S Qie, D Liang, C Yin, W Gu, M Meng, C Wang, N Sang Cell Cycle 11 (19), 3679-3690, 2012 | 59 | 2012 |
PERK is a haploinsufficient tumor suppressor: gene dose determines tumor-suppressive versus tumor promoting properties of PERK in melanoma D Pytel, Y Gao, K Mackiewicz, YV Katlinskaya, KA Staschke, ... PLoS genetics 12 (12), e1006518, 2016 | 54 | 2016 |
Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma S Qie, M Majumder, K Mackiewicz, BV Howley, YK Peterson, PH Howe, ... Nature Communications 8 (1), 1534, 2017 | 53 | 2017 |
Structural insights into E1 recognition and the ubiquitin-conjugating activity of the E2 enzyme Cdc34 KM Williams, S Qie, JH Atkison, S Salazar-Arango, J Alan Diehl, SK Olsen Nature communications 10 (1), 3296, 2019 | 50 | 2019 |
SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors A Yoshida, Y Bu, S Qie, J Wrangle, ER Camp, ES Hazard, G Hardiman, ... Science advances 5 (9), eaax6352, 2019 | 45 | 2019 |
Pilot study on the interaction between B16 melanoma cell-line and bone-marrow derived mesenchymal stem cells T Sun, B Sun, C Ni, X Zhao, X Wang, S Qie, D Zhang, Q Gu, H Qi, N Zhao Cancer letters 263 (1), 35-43, 2008 | 45 | 2008 |
Encyclopedia of cancer P Boffetta, P Hainaut Academic Press, 2018 | 31 | 2018 |
Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells H He, S Qie, Q Guo, S Chen, C Zou, T Lu, Y Su, J Zong, H Xu, D He, Y Xu, ... Cancer management and research, 6411-6424, 2019 | 29 | 2019 |
Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3 A Yoshida, J Choi, HR Jin, Y Li, S Bajpai, S Qie, JA Diehl Oncogene 40 (2), 292-306, 2021 | 24 | 2021 |
A pilot study on acute inflammation and cancer: a new balance between IFN-γ and TGF-β in melanoma Y Ma, T Sun, Y Liu, N Zhao, Q Gu, D Zhang, S Qie, C Ni, Y Liu, B Sun Journal of experimental & clinical cancer research 28, 1-14, 2009 | 21 | 2009 |